Immunization Action Coalition and the Hepatitis B Coalition

IAC EXPRESS

Previous issues index

Home page

Issue Number 348            November 11, 2002

CONTENTS OF THIS ISSUE

  1. CDC releases ACIP recommendations for using yellow fever vaccine
  2. Bruce Gellin, MD, MPH, selected to head federal government's National Vaccine Program Office
  3. Two NFID reports on improving immunization rates in underserved populations now online
  4. New! Volume Five of "Unprotected People" stories is now available online from IAC
  5. "Hepatitis and Corrections" webcast available on the American Correctional Association's website
  6. CDC reports on adverse events associated with yellow fever vaccination
  7. CDC reports on global progress in containing wild polioviruses
  8. New translation! Influenza VIS now in Armenian
  9. NFID's Sixth Annual Conference on Vaccine Research set for May 5-7, 2003
  10. World Vaccine Congress Montreal to be held April 7-9, 2003

----------------------------------------------------------

Back to Top

(1 of 10)
November 11, 2002
CDC RELEASES ACIP RECOMMENDATIONS FOR USING YELLOW FEVER VACCINE

The Centers for Disease Control and Prevention (CDC) published "Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002" in the  November 8 issue of "MMWR Recommendations and Reports." The summary is reprinted below.

**********************

This report updates CDC's recommendations for using yellow fever vaccine (CDC. Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunizations Practices: MMWR 1990;39 [No. RR-6]1-6). The 2002 recommendations include new or updated information regarding 1) reports of yellow fever vaccine-associated viscerotropic disease (previously reported as febrile multiple organ system failure); 2) use of yellow fever vaccine for pregnant women and persons infected with human  immunodeficiency virus (HIV); and 3) concurrent use of yellow fever vaccine with other vaccines. A link to this report and other information related to yellow fever can be accessed at the website for Travelers' Health, Division of Global Migration and Quarantine, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/travel/index.htm and through the website for the Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, CDC, at http://www.cdc.gov/ncidod/dvbid/yellowfever/index.htm

**********************

To obtain the complete text of the report online, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5117a1.htm

To obtain a camera-ready (PDF format) copy of this issue of MMWR Recommendations and Reports, go to: http://www.cdc.gov/mmwr/PDF/rr/rr5117.pdf

The PDF version includes a free CDC-sponsored continuing education activity that can be completed online or submitted via U.S. mail for CME, CEU, or CNE credit. Simply read the MMWR report, answer the questions at the end of the report, and follow the instructions for submitting your answers.

HOW TO OBTAIN A FREE ELECTRONIC SUBSCRIPTION TO THE MMWR:
To obtain a free electronic subscription to the "Morbidity and Mortality Weekly Report" (MMWR), visit CDC's MMWR website at: http://www.cdc.gov/mmwr Select "Free Subscription" from the menu at the left of the screen. Once you have submitted the required information, weekly issues of the MMWR  and all new ACIP statements (published as MMWR's "Recommendations and Reports") will arrive automatically by email.
----------------------------------------------------------

Back to Top

(2 of 10)
November 11, 2002
BRUCE GELLIN, MD, MPH, SELECTED TO HEAD FEDERAL GOVERNMENT'S NATIONAL VACCINE PROGRAM OFFICE

The Immunization Action Coalition congratulates Bruce Gellin, MD, MPH, on being named Director of  the National Vaccine Program Office (NVPO), Office of Public Health and Science, Office of the  Secretary, Department of Health and Human Services. He began his new duties October 28.

A graduate of the University of North Carolina (Morehead Scholar) and Cornell University Medical College, Dr. Gellin is an infectious disease expert with training in epidemiology. He has had broad experience in public health aspects of infectious diseases, having most recently been Director of the National Network for Immunization Information (NNii), a special program of seven medical professional societies. (NNii activities will continue under the leadership of Louis Z. Cooper, MD, immediate past president of the American Academy of Pediatrics.)

NVPO brings together groups that play a key role in immunization--such as federal and state agencies, municipalities, the public, health care providers, and the commercial vaccine industry--to collaborate in the pursuit of preventing infectious diseases through immunization.

To access the NVPO website, go to: http://www.cdc.gov/od/nvpo/who.htm
----------------------------------------------------------

Back to Top

(3 of 10)
November 11, 2002
TWO NFID REPORTS ON IMPROVING IMMUNIZATION RATES IN UNDERSERVED POPULATIONS ARE NOW ONLINE

Two reports on improving immunization rates in underserved populations are now available on the website of the National Foundation for Infectious Diseases (NFID). They are titled "A Report on Reaching Underserved Ethnic and Minority Populations to Improve Pediatric Immunization Rates," which is 24 pages, and "A Report on Reaching Underserved Ethnic and Minority Populations to Improve Adolescent and Adult Immunization Rates," which is 32 pages.

Each report summarizes the work of a roundtable of U.S. and Canadian immunization experts that focused on the problem of vaccinating underserved populations in the United States and Canada. A variety of organizations, representing a diversity of government, as well as ethnic and multicultural groups, contributed. Included in each report are summaries of faculty presentations, a summary of key issues, conclusions, and a reference list.

To obtain a camera-ready (PDF) copy of the pediatric report, go to:
http://www.nfid.org/publications/pediatricwhitepaper.pdf

To obtain a camera-ready (PDF) copy of the adolescent and adult report, go to:
http://www.nfid.org/publications/adoladultwhitepaper.pdf
----------------------------------------------------------

Back to Top

(4 of 10)
November 11, 2002
NEW! VOLUME FIVE OF "UNPROTECTED PEOPLE" STORIES IS NOW AVAILABLE ONLINE FROM IAC

Visit the website of the Immunization Action Coalition (IAC) to obtain the latest collection of "Unprotected People: Stories of People Who Died or Suffered from Vaccine-Preventable Diseases." Volume Five comprises the ten latest personal stories or case reports published in "IAC EXPRESS."

To obtain Volume Five in HTML format, go to:
http://www.immunize.org/catg.d/T2015.htm

To obtain Volume Five in camera-ready (PDF) format, go to:
http://www.immunize.org/catg.d/T2015.pdf

To access any of the five volumes in HTML or PDF format, go to: http://www.immunize.org/catg.d/2057unpr.htm
----------------------------------------------------------

Back to Top

(5 of 10)
November 11, 2002
"HEPATITIS AND CORRECTIONS" WEBCAST AVAILABLE ON THE AMERICAN CORRECTIONAL ASSOCIATION'S WEBSITE

"Hepatitis and Corrections," a national webcast hosted by the American Correctional Association (ACA), is now available on the association's website. The webcast is based on a presentation made August 5 at the 132nd Congress of Correction in Anaheim, CA.

The aim of the webcast is to provide insight on efforts to reduce the spread of viral hepatitis inside correctional facilities. Speakers include Harold Margolis, MD, Director, Division of Viral Hepatitis, Centers for Disease Control and Prevention, as well as officials from the criminal justice and  corrections departments of Texas, Louisiana, and Pennsylvania.

To access the webcast, go to: http://www.aca.org/media_20020805b_hepatitis.htm

To take the program as a course at no charge, and receive CEU and CME credits, register on ACA's Online Corrections Academy website at http://www.aca-oca.org/

For further information, call the Online Corrections Academy at (800) 222-5646, extension 1854.
----------------------------------------------------------

Back to Top

(6 of 10)
November 11, 2002
CDC REPORTS ON ADVERSE EVENTS ASSOCIATED WITH YELLOW FEVER VACCINATION

The Centers for Disease Control and Prevention (CDC) published "Adverse Events Associated with 17-D-Derived Yellow Fever Vaccination--United States, 2001-2002" in the November 8 issue of "Morbidity  and Mortality Weekly Report" (MMWR). The press summary supplied by CDC is reprinted below.

**********************

Between May 2001-October 2002, CDC received reports of six cases of serious neurologic (4) and systemic (2) adverse events associated with yellow fever vaccination. These events are rare. Clinicians are encouraged to report to the Vaccine Adverse Event Reporting System patients with fever (more than 24 hours) or systemic illness within 30 days following vaccination. Despite these rare case reports, yellow fever is an important vaccine-preventable disease among travelers to, and those living in, the tropics of Africa and South America. Because of potential for high risk exposure to and severity of yellow fever infection, and the availability of an efficacious vaccine, ACIP and CDC continue to recommend yellow fever vaccination for persons aged 9 months and older traveling to countries where yellow fever is endemic or epidemic.

***********************

To obtain the complete text of the article online, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5144a1.htm

To obtain a camera-ready (PDF format) copy of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5144.pdf
----------------------------------------------------------

Back to Top

(7 of 10)
November 11, 2002
CDC REPORTS ON GLOBAL PROGRESS IN CONTAINING WILD POLIOVIRUSES

The Centers for Disease Control and Prevention (CDC) published "Global Progress Toward Laboratory Containment of Wild Polioviruses--July 2001-August 2002" in the November 8 issue of "Morbidity and Mortality Weekly Report" (MMWR). The press summary supplied by CDC is reprinted below.

************************

Since the World Health Assembly resolved in 1988 to eradicate poliomyelitis, the number of countries in which wild poliovirus is endemic has decreased from 125 to 10 in 2001. The Global Commission for the Certification of the Eradication of Poliomyelitis will declare the world polio-free when all regions have documented the absence of wild poliovirus transmission for at least 3 consecutive years and when laboratories with wild poliovirus materials have implemented appropriate containment conditions. This report describes preparations for laboratory containment, creation of a global inventory of laboratories and institutions retaining wild poliovirus, and summarizes global progress since July 2001. The data indicate that there has been substantial progress in identifying laboratories with wild poliovirus materials and in conducting national wild poliovirus inventories.

************************

To obtain the complete text of the article online, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5144a2.htm

To obtain a camera-ready (PDF format) copy of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5144.pdf
----------------------------------------------------------

Back to Top

(8 of 10)
November 11, 2002
NEW TRANSLATION! INFLUENZA VIS NOW IN ARMENIAN

The 2002-2003 Influenza Vaccine Information Statement (VIS) in Armenian is now available on the Immunization Action Coalition (IAC) website. IAC gratefully acknowledges the County of Los Angeles, Department of Health Services Immunization Program for providing the Armenian translation.

To obtain a camera-ready (PDF) copy of the influenza VIS in Armenian, go to:
http://www.immunize.org/vis/ar_flu02.pdf

To obtain a copy camera-ready (PDF) of the influenza VIS in English, go to: http://www.immunize.org/vis/2flu.pdf

For more information about the use of VISs, and for VISs in a total of 28 languages, visit IAC's VIS web page at http://www.immunize.org/vis/
----------------------------------------------------------

Back to Top

(9 of 10)
November 11, 2002
NFID'S SIXTH ANNUAL CONFERENCE ON VACCINE RESEARCH SET FOR MAY 5-7, 2003

The National Foundation for Infectious Diseases (NFID) announced the Sixth Annual Conference on Vaccine Research will take place at the Crystal Gateway Marriott, Arlington, VA, on May 5-7, 2003.

Intended to further networking and scientific collaboration among vaccine researchers, the conference will focus on basic immunology, vaccine development, clinical testing, and vaccine regulation.

For information, call Sharon Cooper-Kerr or Sheena Majette at (301) 656-0003, extension 19, or email them at vaccine@nfid.org
----------------------------------------------------------

Back to Top

(10 of 10)
November 11, 2002
WORLD VACCINE CONGRESS MONTREAL TO BE HELD APRIL 7-9, 2003

World Vaccine Congress Montreal is set for April 7-9, 2003, at the Hilton Montreal Bonaventure, Montreal, Canada. It is intended for senior people across the North American vaccine industry.

For information, call Sarah Butt at +44 (0)20 7827-5962 or email her at sarah.butt@terrapin.com 

 

Immunization Action Coalition1573 Selby AvenueSt. Paul MN 55104
E-mail: admin@immunize.org Web: http://www.immunize.org/
Tel: (651) 647-9009Fax: (651) 647-9131

This page was updated on November 11, 2002